Sudden Cardiac Arrest Related to Sport in Young and Value of the Genetic Assessment: a French Prospective Register
Key facts
- Who runs it
- Rennes University Hospital
- Where
- France26 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 80 people, planned
- Started
- 11 Oct 2024
- Expected to end
- 11 Jan 2028
- Type of study
- Observational
- Treatments tested
- Whole exome sequencing to detect myocardial genetic mutations (SCA group only)
- Record updated
- 25 August 2026
Who can take part
- Age
- 12 years to 35 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Victims of SCA:; Aged between 12 and 35 years; No known cardiovascular pathology; Experienced a sudden and non-traumatic SCA during or within one hour of participating in sports activities (leisure, training, or competition); For resuscitated victims (SCA group): A person or legal representative who does not oppose participation in the research after being informed about the study (including individuals, organs, or authorities responsible for assisting or representing them if they are unable to express their wishes); For non-resuscitated victims (SCD group): A person who has not formally objected to the reuse of their medical data during their lifetime
- First-Degree Relatives:; A person or legal representative who does not oppose participation in the research after being informed about the study (including individuals, bodies, or authorities responsible for assisting or representing them if they are unable to express their wishes); Non-Inclusion Criteria:
- For resuscitated SCA cases, individuals weighing less than 20 kg
- Victims or legal representatives who are subject to legal protection or deprived of their liberty
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 12 and 35 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The increased risk of sudden cardiac arrest (SCA) or sudden cardiac death (SCD) related to vigorous physical activity is well-documented. Currently, for young victims (under 35 years) of SCA/SCD, no etiology is found in 40 to 50% of cases after a standard medical assessment, leading to two important consequences. For the victim's family, it is difficult to understand and accept this tragic event, and the risk of it occurring in another family member is a source of concern. Medically, the absence of a known cause limits the ability to effectively prevent such events.
Read full original descriptionShow less
The RESOUDRE study will be a national, prospective, observational registry of young victims (12-35 years) of sports-related SCA/SCD. All cases will undergo the recommended etiological assessment, including autopsy for SCA cases, along with whole exome genetic analysis and toxicological testing. In the event a genetic pathology is identified, a genetic evaluation will be offered to other family members, and appropriate medical care will be provided if necessary. The results of this study could significantly reduce the number of unexplained sport-related SCA/SCD cases and aid in preventing these incidents among affected families.
The group in the trial
- Victims of sport-related sudden cardiac arrest (SCA) : resuscitated SCA and non-resuscitated SCA
Following a sport-related sudden cardiac arrest (SCA), resuscitation attempts are frequently made due to the high likelihood of witnesses at the scene. These resuscitation efforts are successful in more than 40% of cases. The study population will therefore be divided into two groups: a group of resuscitated SCA victims (SCA group) and a group of non-resuscitated or unsuccessfully resuscitated victims (SCD group). The RESOUDRE study is an observational study focusing on individuals who have experienced SCA. Depending on the outcome-whether the individual survives or not-the etiological assessment will differ. While the study design refers to two distinct groups for clarity, they represent a single population, and no statistical comparison between the two groups will be made.
Treatment: Whole exome sequencing to detect myocardial genetic mutations (SCA group only)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Registre Prospectif français Des Morts Subites Chez Des Sportifs Jeunes
- Criteria questions
- Built from NCT06642168, who can take part
- Record updated
- 25 August 2026